We are live on
!
Find out more
Group One Trading Portfolio holdings
AUM
$52.2B
1-Year Est. Return
104.56%
This Fund
S&P 500
This Quarter
Est. Return
+9.94%
1 Year Est. Return
+104.56%
3 Year Est. Return
+314.05%
5 Year Est. Return
+338.55%
10 Year Est. Return
+1,999.92%
AUM
$43B
AUM Growth
-$7.89B
(-16%)
Cap. Flow
-$3.97B
Cap. Flow
% of AUM
-9.24%
Top 10 Holdings %
Top 10 Hldgs %
21.79%
Holding
8,577
New
1,058
Increased
2,469
Reduced
3,270
Closed
1,444
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cigna
CI
|
+$158M |
| 2 |
Microsoft
MSFT
|
+$62.9M |
| 3 |
Meta Platforms (Facebook)
META
|
+$55.8M |
| 4 |
Boeing
BA
|
+$34.1M |
| 5 |
ARK Innovation ETF
ARKK
|
+$29.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$128M |
| 2 |
NVIDIA
NVDA
|
+$89M |
| 3 |
Apple
AAPL
|
+$86.7M |
| 4 |
Advanced Micro Devices
AMD
|
+$47.6M |
| 5 |
Biogen
BIIB
|
+$30.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 1.37% |
| 2 | Healthcare | 1.33% |
| 3 | Consumer Discretionary | 0.84% |
| 4 | Energy | 0.65% |
| 5 | Financials | 0.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3276
PUT
Relmada Therapeutics
RLMD
$484M
| $387K | ﹤0.01% |
110,900
-328,500
| -75% | -$2.89M |
|
|
DENN
3277
PUT
DELISTED
Denny's
DENN
| $387K | ﹤0.01% |
42,000
+31,500
| +300% | +$341K |
|
|
ADVM
3278
CALL
DELISTED
Adverum Biotechnologies
ADVM
| $386K | ﹤0.01% |
66,690
-10,290
| -13% | -$78K |
|
|
NVEI
3279
PUT
DELISTED
Nuvei Corporation Subordinate Voting Shares
NVEI
| $386K | ﹤0.01% |
15,200
-100
| -0.7% | -$2.83K |
|
3280
PUT
Purple Innovation
PRPL
$39.6M
| $386K | ﹤0.01% |
3,224
-120
| -4% | -$13.1K |
|
3281
CALL
Associated Banc-Corp
ASB
$5.92B
| $386K | ﹤0.01% |
16,700
| – | – |
|
|
TRVG
3282
trivago
TRVG
$376M
| $385K | ﹤0.01% |
57,052
-31,418
| -36% | -$193K |
|
3283
PUT
Cytokinetics
CYTK
$10.8B
| $385K | ﹤0.01% |
8,400
+2,200
| +35% | +$94.7K |
|
|
DM
3284
CALL
DELISTED
Desktop Metal, Inc.
DM
| $385K | ﹤0.01% |
28,300
-196,780
| -87% | -$4.1M |
|
|
NXDR
3285
Nextdoor Holdings
NXDR
$1.04B
| $384K | ﹤0.01% |
186,439
+30,752
| +20% | +$72K |
|
3286
PUT
IonQ
IONQ
$17.2B
| $384K | ﹤0.01% |
111,200
-61,600
| -36% | -$297K |
|
|
ZUO
3287
PUT
DELISTED
Zuora, Inc.
ZUO
| $384K | ﹤0.01% |
+60,300
| New | +$426K |
|
3288
CALL
LivaNova
LIVN
$4.21B
| $383K | ﹤0.01% |
6,900
-74,000
| -91% | -$3.78M |
|
3289
Ginkgo Bioworks
DNA
$515M
| $383K | ﹤0.01% |
5,661
+1,678
| +42% | +$154K |
|
3290
CALL
Kimbell Royalty Partners
KRP
$1.49B
| $382K | ﹤0.01% |
22,900
-80,300
| -78% | -$1.41M |
|
3291
CALL
Hudbay
HBM
$12.4B
| $382K | ﹤0.01% |
75,400
+52,000
| +222% | +$251K |
|
|
CIM
3292
PUT
Chimera Investment
CIM
$980M
| $382K | ﹤0.01% |
23,167
+11,300
| +95% | +$211K |
|
3293
CALL
Procore
PCOR
$8.84B
| $382K | ﹤0.01% |
8,100
+5,100
| +170% | +$260K |
|
3294
CALL
Sigma Lithium
SGML
$1.32B
| $381K | ﹤0.01% |
13,500
+8,700
| +181% | +$280K |
|
3295
LSB Industries
LXU
$726M
| $380K | ﹤0.01% |
+28,591
| New | +$426K |
|
|
CMBT
3296
PUT
CMB.TECH NV
CMBT
$4.67B
| $380K | ﹤0.01% |
22,300
+5,100
| +30% | +$92K |
|
3297
CALL
Protalix BioTherapeutics
PLX
$200M
| $380K | ﹤0.01% |
277,300
-76,000
| -22% | -$83.4K |
|
3298
CALL
Assured Guaranty
AGO
$3.34B
| $380K | ﹤0.01% |
6,100
+5,900
| +2,950% | +$350K |
|
3299
PUT
Winnebago Industries
WGO
$906M
| $379K | ﹤0.01% |
7,200
-72,000
| -91% | -$4.1M |
|
|
CARM
3300
PUT
DELISTED
Carisma Therapeutics
CARM
| $379K | ﹤0.01% |
31,110
-5,800
| -16% | -$60.9K |
|
Similar funds
SCP
RIM
Group One Trading's Q4 2022 Portfolio in Review
As of Q4 2022, Group One Trading held 8,577 positions worth $43B, down 16% from $50.9B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Group One Trading withdrew a net $3.97B in Q4 2022, closing 1,444 positions and reducing 3,270 holdings. Its most notable exit was Biogen, an estimated $30.6M position sold in full.
By sector, the portfolio is most concentrated in Technology at 1.4% of assets, down from 1.5% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Group One Trading opened a new position in Cigna worth $165M.
- Group One Trading's largest Q4 2022 buy was Cigna: 497,989 shares worth $165M.
- Group One Trading added most to Microsoft in Q4 2022, an estimated $62.9M increase.
- Group One Trading's biggest Q4 2022 reduction was Tesla, cutting an estimated $128M.
- Group One Trading fully exited Biogen in Q4 2022, selling an estimated $30.6M.
- Group One Trading's ten largest holdings make up 22% of its $43B portfolio in Q4 2022.
- Group One Trading opened 1,058 new positions and closed 1,444 in Q4 2022.
- Group One Trading's portfolio value fell 16% quarter-over-quarter to $43B.
Based on Group One Trading's 13F filing for Q4 2022, filed 9 Feb 2023.